Department of Anatomy, College of Medicine, University of Mosul, Mosul, Iraq
*Corresponding Author E-mail: aad@uomosul.edu.iq
Online published on 8 June, 2021.
In March 2020 the world officially released its first approach to the coronaviral pandemic to explain the rationale for using hydroxychloroquine. It was also believed to calm down the immune system during viral infections. The FDA warned using hydroxychloroquien for SARS-CoV-2. In this short letter we address why the FDA discontinued the treatment of the novel coronavirus with hydroxychloroquine.
SARS-CoV-2, Hydroxycholoroquine, Traetmnet, Reasons
